A novel functional low-density lipoprotein receptor-related protein 6 gene alternative splice variant is associated with Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neurobiology of Aging

• Publication date

  2013-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neurobiolaging.2012.11.004PMID 23218566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MAPT Isoforms: Differential Transcriptional Profiles Related to 3R and 4R Splice Variants

  2011cited by this paper
• Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication.

  2011cited by this paper
• Whole Transcriptome Sequencing Reveals Gene Expression and Splicing Differences in Brain Regions Affected by Alzheimer's Disease

  2011cited by this paper
• Canonical Wnt3a Modulates Intracellular Calcium and Enhances Excitatory Neurotransmission in Hippocampal Neurons*

  2010cited by this paper
• Housekeepers for accurate transcript expression analysis in Alzheimer's disease autopsy brain tissue

  2010influential reference
• Genetic control of human brain transcript expression in Alzheimer disease.

  2009cited by this paper
• Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

  2009cited by this paper
• A Common Variant in Low-Density Lipoprotein Receptor–Related Protein 6 Gene (LRP6) Is Associated With LDL-Cholesterol

  2009cited by this paper
• Wnt-7a Modulates the Synaptic Vesicle Cycle and Synaptic Transmission in Hippocampal Neurons*

  2008cited by this paper
• Wnt Regulates Axon Behavior through Changes in Microtubule Growth Directionality: A New Role for Adenomatous Polyposis Coli

  2008cited by this paper
• A second generation human haplotype map of over 3.1 million SNPs

  2007cited by this paper
• Common genetic variation within the Low-Density Lipoprotein Receptor-Related Protein 6 and late-onset Alzheimer's disease

  2007cited by this paper
• Evidence for an enhancement of excitatory transmission in adult CNS by Wnt signaling pathway modulation.

  2007cited by this paper
• Expression of APP pathway mRNAs and proteins in Alzheimer's disease.

  2007cited by this paper
• LRP6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors

  2007cited by this paper
• α-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer’s disease

  2007cited by this paper
• Genome-wide detection and characterization of positive selection in human populations

  2007cited by this paper
• Gene splicing and mutagenesis by PCR-driven overlap extension

  2007cited by this paper
• A survey of genetic human cortical gene expression

  2007cited by this paper
• Population genomics of human gene expression

  2007cited by this paper
• The ups and downs of Wnt signaling in prevalent neurological disorders

  2006cited by this paper
• Activity-dependent Synaptic Wnt Release Regulates Hippocampal Long Term Potentiation*

  2006cited by this paper
• Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism.

  2006cited by this paper
• Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release

  2006cited by this paper
• Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells

  2006cited by this paper
• Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression

  2006cited by this paper
• Association between Glycogen Synthase Kinase-3β Genetic Polymorphism and Late-Onset Alzheimer’s Disease

  2006cited by this paper
• Wnt signalling regulates adult hippocampal neurogenesis

  2005cited by this paper
• Common Genetic Variation of the Low‐Density Lipoprotein Receptor‐Related Protein 5 and 6 Genes Determines Fracture Risk in Elderly White Men

  2005cited by this paper
• Lipoprotein particles are required for Hedgehog and Wingless signalling

  2005cited by this paper
• Synaptic contact dynamics controlled by cadherin and catenins.

  2005cited by this paper
• LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling: Arrows point the way

  2004cited by this paper
• Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets

  2004cited by this paper
• Variation in alternative splicing across human tissues

  2004cited by this paper
• Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease.

  2004cited by this paper
• Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Associated with Neuronal Degeneration in Alzheimer's Brain

  2004cited by this paper
• Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.

  2004cited by this paper
• The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains.

  2004cited by this paper
• Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons.

  2004cited by this paper
• WNT and β-catenin signalling: diseases and therapies

  2004cited by this paper
• WNT and beta-catenin signalling: diseases and therapies.

  2004cited by this paper
• Wnt-3a overcomes β-amyloid toxicity in rat hippocampal neurons

  2004cited by this paper
• Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel-based tool using pair-wise correlations

  2004cited by this paper
• GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

  2003cited by this paper
• Quantification of regional glial fibrillary acidic protein levels in Alzheimer's disease

  2003cited by this paper
• Alzheimer's disease linking neurodegeneration with neurodevelopment.

  2003cited by this paper
• Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.

  2003cited by this paper
• The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease?

  2003cited by this paper
• Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss

  2003cited by this paper
• Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by β-amyloid fibrils

  2003cited by this paper
• Pre-mRNA splicing and human disease.

  2003cited by this paper
• Gene structure and alternative splicing of glycogen synthase kinase 3 beta (GSK-3beta) in neural and non-neural tissues.

  2003cited by this paper
• GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

  2003cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Alzheimer's disease-do tauists and baptists finally shake hands?

  2002cited by this paper
• Aberrant Tau Phosphorylation by Glycogen Synthase Kinase-3β and JNK3 Induces Oligomeric Tau Fibrils in COS-7 Cells*

  2002cited by this paper
• Alternative splicing and genome complexity

  2002cited by this paper
• Identification of genomic organisation, sequence variants and analysis of the role of the human dishevelled 1 gene in late onset Alzheimer's disease

  2002cited by this paper
• Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

  2002cited by this paper
• Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100.

  2002cited by this paper
• Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease.

  2002cited by this paper
• Alternative splicing: multiple control mechanisms and involvement in human disease.

  2002cited by this paper
• Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis.

  2002cited by this paper
• Dishevelled Regulates the Metabolism of Amyloid Precursor Protein via Protein Kinase C/Mitogen-Activated Protein Kinase and c-Jun Terminal Kinase

  2001cited by this paper
• Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice

  2001cited by this paper
• Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway.

  2001cited by this paper
• Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 β gene and promoter in late onset Alzheimer's disease

  2001cited by this paper
• Wnt signaling function in Alzheimer's disease.

  2000cited by this paper
• Broadly altered expression of the mRNA isoforms of FE65, a facilitator of beta amyloidogenesis, in Alzheimer cerebellum and other brain regions

  2000influential reference
• Quantitative evaluation of the rRNA in Alzheimer's disease.

  2000cited by this paper
• RNA processing and human disease

  2000cited by this paper
• Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway.

  2000cited by this paper
• Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes.

  1999cited by this paper
• Distribution of Active Glycogen Synthase Kinase 3β (GSK-3β) in Brains Staged for Alzheimer Disease Neurofibrillary Changes

  1999cited by this paper
• Variable mutation frequencies in coding repeats of TCF-4 and other target genes in colon, gastric and endometrial carcinoma showing microsatellite instability

  1999cited by this paper
• A new low density lipoprotein receptor related protein, LRP5, is expressed in hepatocytes and adrenal cortex, and recognizes apolipoprotein E.

  1998cited by this paper
• Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.

  1998cited by this paper
• Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau.

  1998cited by this paper
• Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis

  1998cited by this paper
• Presenilin 1 interaction in the brain with a novel member of the Armadillo family

  1997cited by this paper
• Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.

  1994cited by this paper
• Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type.

  1993cited by this paper
• Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.

  1992cited by this paper

• Brain–Bone Axis in Physiological and Pathological Conditions

  2025cites this paper
• Mind Gaps and Bone Snaps: Exploring the Connection Between Alzheimer’s Disease and Osteoporosis

  2024cites this paper
• Age- and Sex-Associated Wnt Signaling Dysregulation is Exacerbated from the Early Stages of Neuropathology in an Alzheimer’s Disease Model

  2024cites this paper
• Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach.

  2024cites this paper
• Wnt/β-catenin Signaling in Central Nervous System Regeneration.

  2024cites this paper
• BML-281 promotes neuronal differentiation by modulating Wnt/Ca2+ and Wnt/PCP signaling pathway

  2023cites this paper
• A genetic variant of the Wnt receptor LRP6 accelerates synapse degeneration during aging and in Alzheimer’s disease

  2023influential citation
• Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer’s disease, restores synapse integrity and memory in a disease mouse model

  2023cites this paper
• Restoring synapse integrity and memory in Alzheimer’s disease by downregulation of the Wnt antagonist Dickkopf-3

  2022cites this paper
• A genetic variant of the Wnt receptor LRP6 accelerates synapse degeneration during ageing and in Alzheimer’s disease

  2022cites this paper
• Suppression of Wnt/β-Catenin Signaling Is Associated with Downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer’s Disease

  2022cites this paper
• Urokinase-Type Plasminogen Activator Triggers Wingless/Int1-Independent Phosphorylation of the Low-Density Lipoprotein Receptor-Related Protein-6 in Cerebral Cortical Neurons

  2022cites this paper
• Activation of Wnt/β-catenin pathway mitigates blood–brain barrier dysfunction in Alzheimer’s disease

  2022cites this paper
• The transcriptional landscape of Alzheimer's disease and its association with Wnt signaling pathway.

  2021cites this paper
• Rare phenotype: Hand preaxial polydactyly associated with LRP6-related tooth agenesis in humans

  2021cites this paper
• Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic Diseases

  2021cites this paper
• Regulation of the Low-Density Lipoprotein Receptor-Related Protein LRP6 and Its Association With Disease: Wnt/β-Catenin Signaling and Beyond

  2021cites this paper
• Epigenetic repression of Wnt receptors in AD: a role for Sirtuin2-induced H4K16ac deacetylation of Frizzled1 and Frizzled7 promoters

  2021influential citation
• The Role of BMI1 in Late-Onset Sporadic Alzheimer’s Disease

  2020cites this paper
• Wnt signalling pathway and tau phosphorylation: A comprehensive study on known connections.

  2020cites this paper
• Role of Wnt Signaling in Adult Hippocampal Neurogenesis in Health and Disease

  2020cites this paper
• Dickkopf-related protein-1 inhibition attenuates amyloid-beta pathology associated to Alzheimer's disease.

  2020cites this paper
• Dysregulated Wnt Signalling in the Alzheimer’s Brain

  2020cites this paper
• The cAMP/PKA Pathway Inhibits Beta-amyloid Peptide Release from Human Platelets.

  2019cites this paper
• Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease

  2019cites this paper
• Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer's disease.

  2018cites this paper
• The involvement of the canonical Wnt‐signaling receptor LRP5 and LRP6 gene variants with ADHD and sexual dimorphism: Association study and meta‐analysis

  2018cites this paper
• Deficient Wnt Signaling and Synaptic Vulnerability in Alzheimer’s Disease: Emerging Roles for the LRP6 Receptor

  2018cites this paper
• Impaired Wnt Signaling in the Prefrontal Cortex of Alzheimer’s Disease

  2018cites this paper
• Wnt/β-catenin signaling stimulates the expression and synaptic clustering of the autism-associated Neuroligin 3 gene

  2018cites this paper
• Strong Association of Lipid Metabolism Related MicroRNA Binding Sites Polymorphisms with the Risk of Late Onset Alzheimer's Disease.

  2017cites this paper
• Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases

  2017cites this paper
• Recent Developments in Understanding Brain Aging: Implications for Alzheimer's Disease and Vascular Cognitive Impairment.

  2016cites this paper
• Reversal of Synapse Degeneration by Restoring Wnt Signaling in the Adult Hippocampus

  2016cites this paper
• The role of the Wnt canonical signaling in neurodegenerative diseases.

  2016cites this paper
• Towards improved genome-scale metabolic network reconstructions: unification, transcript specificity and beyond

  2015cites this paper
• Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer’s disease

  2015cites this paper
• Wnt co-receptor LRP5/6 overexpression confers protection against hydrogen peroxide-induced neurotoxicity and reduces tau phosphorylation in SH-SY5Y cells.

  2015cites this paper
• Novel mutations in Lrp6 orthologs in mouse and human neural tube defects affect a highly dosage-sensitive Wnt non-canonical planar cell polarity pathway.

  2014cites this paper
• Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum.

  2014cites this paper
• New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease

  2014cites this paper
• Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer's disease.

  2014cites this paper
• Wnt/β-catenin signaling in Alzheimer's disease.

  2014cites this paper
• Homocysteine Contributes to Pathogenesis by Oxidative Stress for Alzheimer's Disease

  2013cites this paper